Logo Lanfrica

Implementing a Short Regimen for Multidrug-Resistant Tuberculosis in Kinshasa, Democratic Republic of Congo: A Cohort Study 2014-2017

Creator:
InnLeoFinNic
Publisher:
Sci
Host:

Licenses

http://creativecommons.org/licenses/by/4.0/

Similar

Low Detection Rate of Multidrug-Resistant and Rifampicin-Resistant Tuberculosis in the Democratic Republic of Congo: Trend Analysis 2013-2017

Outcomes and adverse events of pre- and extensively drug-resistant tuberculosis patients in Kinshasa, Democratique Republic of the Congo: A retrospective cohort study

Multidrug-Resistant Tuberculosis in the Democratic Republic of Congo: Analysis of Continuous Surveillance Data from 2007 to 2016

Dengue and Chikungunya among Febrile Outpatients in Kinshasa, Democratic Republic of Congo: a cross-sectional study

Background Pathogens causing acute fever, with the exception of malaria, remain largely unidentified

Successful management of multidrug-resistant tuberculosis with shorter treatment regimen in niger

Aims and objectives: Niger is a challenging environment, with limited resources for TB

Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant Tuberculosis Regimen in a Rural Setting in Angola

Treatment for multidrug-resistant tuberculosis (MDR TB) is associated with adverse events (AE). Pati